|
⚲
|
| Keyboard |
| Aktis Oncology Inc
✚
|
|
|---|---|
| CIK # | 0002035832 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0002035832] | |
| 10-Q | [0002035832] | |
| 3 | [0002035832] | |
| 4 | [0002035832] | |
| 8-K | [0002035832] | |
| D | [0002035832] | |
| SC 13D | [0002035832] | |
| SC 13G | [0002035832] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Buy | 2,077,779 | $18.00 | 37,400,022 |
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Conversion | 128,506 | ||
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Conversion | 202,862 | ||
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Conversion | 2,270,879 | ||
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Buy | 144,443 | $18.00 | 2,599,974 |
|
Aktis Oncology Inc AKTS
Series A Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 9,913,810 | ||
|
Aktis Oncology Inc AKTS
Series A Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 997,299 | ||
|
Aktis Oncology Inc AKTS
Series A Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 488,891 | ||
|
Aktis Oncology Inc AKTS
Series B Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 2,397,500 | ||
|
Aktis Oncology Inc AKTS
Class A Common Stock · derivative
|
2026-01-12 | Conversion | 965,190 | ||
|
Aktis Oncology Inc AKTS
Class A Common Stock · derivative
|
2026-01-12 | Conversion | 86,222 | ||
|
Aktis Oncology Inc AKTS
Series B Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 102,500 | ||
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Conversion | 4,859,370 | ||
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Buy | 22,545 | $18.00 | 405,810 |
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Conversion | 134,842 | ||
|
Aktis Oncology Inc AKTS
Common Stock
|
2026-01-12 | Buy | 812,455 | $18.00 | 14,624,190 |
|
Aktis Oncology Inc AKTS
Series A Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 14,838,250 | $0.00 | |
|
Aktis Oncology Inc AKTS
Series B Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 101,250 | $0.00 | |
|
Aktis Oncology Inc AKTS
Series B Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 3,648,750 | $0.00 | |
|
Aktis Oncology Inc AKTS
Series A Redeemable Convertible Preferred Stock · derivative
|
2026-01-12 | Conversion | 411,750 | $0.00 | |
| showing 20 of 52 most recent transactions | |||||